Skip to main content

Advertisement

Log in

The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Surgical resection is not the standard of care for primary central nervous system lymphoma (PCNSL), as historical studies have demonstrated unfavorable complication rates and limited benefits. Some recent studies suggest that resection may provide a therapeutic benefit, yet the safety of these procedures has not been systematically investigated in the setting of modern neurosurgery. We examined the safety of surgical resection for PCNSL. We retrospectively analyzed all patients with PCNSL treated at Columbia University Medical Center between 2000 and 2015 to assess complications rates following biopsy or resection using the Glioma Outcomes Project system. We identified predictors of complications and selection for resection. Well-validated scales were used to quantify patients’ baseline clinical characteristics, including functional status, comorbid disease burden, and cardiac risk. The overall complication rate was 17.2% after resection, and 28.2% after biopsy. Cardiac risk (p = 0.047, OR 1.72 [1.01, 2.95]), and comorbid diagnoses (p = 0.004, OR 3.05 [1.42, 6.57]) predicted complications on multivariable regression. Patients who underwent resection had better KPS scores (median 70 v. 80, p = 0.0068, ∆ 10 [0.0, 10.00]), and were less likely to have multiple (46.5% v. 27.6%, p = 0.030, OR 1.42 [1.05, 1.92]) or deep lesions (70.4% v. 39.7%, p = 0.001, OR 1.83 [1.26, 2.65]). Age (p = 0.048, OR 0.75 per 10-year increase [0.56, 1.00]) and deep lesions (p = 0.003, OR 0.29 [0.13, 0.65]) influenced selection for resection on multivariable regression. Surgical resection of PCNSL is safe for select patients, with complication rates comparable to rates for other intracranial neoplasms. Whether there is a clinical benefit to resection cannot be concluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261–266

    Article  Google Scholar 

  2. Weller M, Martus P, Roth P, Thiel E, Korfel A (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14:1481–1484

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bierman PJ (2014) Surgery for primary central nervous system lymphoma: is it time for reevaluation? Oncology (Williston Park, NY) 28

  4. Siasios I, Fotiadou A, Fotakopoulos G, Ioannou M, Anagnostopoulos V, Fountas K (2015) Primary diffuse large B-cell lymphoma of central nervous system: is still surgery an unorthodox treatment? J Clin Med Res 7:1007

    Article  PubMed  PubMed Central  Google Scholar 

  5. Henry JM, Heffner RR, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34:1293–1302

    Article  CAS  PubMed  Google Scholar 

  6. DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G (1990) Primary CNS lymphoma combined treatment with chemotherapy and radiotherapy. Neurology 40:80–80

    Article  CAS  PubMed  Google Scholar 

  7. Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of the central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 65:600–607

    Article  CAS  PubMed  Google Scholar 

  8. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150

    Article  CAS  PubMed  Google Scholar 

  9. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O’Fallon JR, Kelly PJ, Jack Jr CR, O’Neill BP (1995) Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 82:558–566

    Article  CAS  PubMed  Google Scholar 

  10. Frank G, Ferracini R, Spagnolli F, Frank F, Gaist G, Lorenzini P, Ricci R (1985) Primary intracranial lymphomas. Surg Neurol 23:3–8

    Article  CAS  PubMed  Google Scholar 

  11. Gonzalez DG, Schuster-Uitterhoeve ALJ (1983) Primary non-Hodgkin’s lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51:2048–2052

    Article  CAS  PubMed  Google Scholar 

  12. Helle TL, Britt RH, Colby TV (1984) Primary lymphoma of the central nervous system: clinicopathological study of experience at Stanford. J Neurosurg 60:94–103

    Article  CAS  PubMed  Google Scholar 

  13. Mendenhall NP, Thar TL, Frank O, Harty-Golder B, Ballinger WE, Million RR (1983) Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer 52:1993–2000

    Article  CAS  PubMed  Google Scholar 

  14. Marcus R, Hodson D, Coupland S, Bessell E, Mead B, Pettitt AR (2009) Guidelines on the diagnosis and management of adult patients with primary CNS lymphoma (PCNSL) and primary intra-ocular lymphoma (PIOL)

  15. Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol (EJSO) 31:100–105

    Article  CAS  Google Scholar 

  16. Finks JF, Osborne NH, Birkmeyer JD (2011) Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 364:2128–2137. doi:10.1056/NEJMsa1010705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Deyo RA, Mirza SK, Martin BI, Kreuter W, Goodman DC, Jarvik JG (2010) Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 303:1259–1265

  18. Patil PG, Turner DA, Pietrobon R (2005) National trends in surgical procedures for degenerative cervical spine disease: 1990–2000. Neurosurgery 57:753–758

  19. Cheney FW, Posner KL, Lee LA, Caplan RA, Domino KB (2006) Trends in anesthesia-related death and brain damage. Anesthesiology 105:1081–1086

    Article  PubMed  Google Scholar 

  20. Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D (2012) Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA 307:2400–2409

    Article  CAS  PubMed  Google Scholar 

  21. Gumprecht HK, Widenka DC, Lumenta CB (1999) BrainLab VectorVision Neuronavigation System: technology and clinical experiences in 131 cases. Neurosurgery 44:97–104

  22. Schebesch K-M, Hoehne J, Hohenberger C, Acerbi F, Broggi M, Proescholdt M, Wendl C, Riemenschneider MJ, Brawanski A (2015) Fluorescein sodium-guided surgery in cerebral lymphoma. Clin Neurol Neurosurg 139:125–128

  23. Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C, Abacioglu U (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16:e322–e332

  24. Karnofsky DA (1949) The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents

  25. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma outcome project. J Neurosurg 98:1175–1181. doi:10.3171/jns.2003.98.6.1175

    Article  PubMed  Google Scholar 

  26. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049

  27. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

  28. D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM (2015) The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurg. doi:10.1016/j.wneu.2015.05.072.

  29. Patil CG, Lad SP, Santarelli J, Boakye M (2007) National inpatient complications and outcomes after surgery for spinal metastasis from 1993 to 2002. Cancer 110:625–630

    Article  PubMed  Google Scholar 

  30. Curry WT, McDermott MW, Carter BS, Barker FG 2nd (2005) Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 102:977–986. doi:10.3171/jns.2005.102.6.0977

    Article  PubMed  Google Scholar 

  31. Barker FG 2nd, Curry WT Jr, Carter BS (2005) Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol 7:49–63. doi:10.1215/S1152851704000146

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zada G, Du R, Laws Jr ER (2011) Defining the “edge of the envelope”: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy: clinical article. J Neurosurg 114:286–300

    Article  PubMed  Google Scholar 

  33. Brell M, Ibanez J, Caral L, Ferrer E (2000) Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 142:739–750

    Article  CAS  Google Scholar 

  34. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi W-M, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055

    Article  CAS  PubMed  Google Scholar 

  35. Hoover JM, Nwojo M, Puffer R, Mandrekar J, Meyer FB, Parney IF (2013) Surgical outcomes in recurrent glioma. J Neurosurg. doi:10.3171/2013.2.JNS121731

    PubMed Central  Google Scholar 

  36. Moiyadi AV, Shetty PM (2012) Perioperative outcomes following surgery for brain tumors: objective assessment and risk factor evaluation. J Neurosci Rural Pract 3:28

  37. Talacchi A, Turazzi S, Locatelli F, Sala F, Beltramello A, Alessandrini F, Manganotti P, Lanteri P, Gambin R, Ganau M, Tramontano V, Santini B, Gerosa M (2010) Surgical treatment of high-grade gliomas in motor areas. The impact of different supportive technologies: a 171-patient series. J Neurooncol 100:417–426. doi:10.1007/s11060-010-0193-x

    Article  PubMed  Google Scholar 

  38. Malone HR, Cloney M, Yang J, Neugut AI, Bruce JN (2015) Hospital surgical volume as a source of variation in failure to rescue and inpatient mortality following craniotomy for resection of intracranial neoplasms. 2015 congress of neurological surgeons annual meeting. Congress of Neurological Surgeons, New Orleans, LA

  39. Benz RJ, Ibrahim ZG, Afshar P, Garfin SR (2001) Predicting complications in elderly patients undergoing lumbar decompression. Clin Orthop Relat Res 384:116–121

    Article  Google Scholar 

  40. Birim Ö, Maat A, Kappetein AP, Van Meerbeeck JP, Damhuis RAM, Bogers A (2003) Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardio-thorac Surg 23:30–34

  41. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM, Har-El G, Lucente FE (1997) Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 107:1469–1475

  42. Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF (2013) Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg 118:786–798 doi:10.3171/2012.10.JNS112268

    Article  PubMed  Google Scholar 

  43. Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853

    Article  CAS  PubMed  Google Scholar 

  44. Michalski JM, Garcia DM, Kase E, Grigsby PW, Simpson JR (1990) Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176:855–860

    Article  CAS  PubMed  Google Scholar 

  45. Pollack IF, Dade Lunsford L, Flickinger JC, Lee Dameshek H (1989) Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63:939–947

    Article  CAS  PubMed  Google Scholar 

  46. Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE (2009) Glioblastoma in the elderly: the memorial Sloan-Kettering cancer center experience (1997–2007). Cancer 115:3758–3766 doi:10.1002/cncr.24413

    Article  PubMed  Google Scholar 

  47. Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H (2016) Defining glioblastoma resectability through the wisdom of the crowd: a proof-of-principle study. Neurosurgery

  48. Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg. doi:10.3171/2012.8.jns12234

    PubMed  Google Scholar 

Download references

Funding

NIH office of the Director, Award Number 1DP5OD021356-01, and Diversity Recruitment Award by the Office of Senior Associate Provost for Faculty Diversity and Inclusion, Columbia University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam M. Sonabend.

Ethics declarations

Conflict of interest

None.

Additional information

Michael Brendan Cloney and Adam Sonabend contributed equally to this manuscript, and are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cloney, M.B., Sonabend, A.M., Yun, J. et al. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis. J Neurooncol 132, 189–197 (2017). https://doi.org/10.1007/s11060-016-2358-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2358-8

Keywords

Navigation